-
公开(公告)号:US5684205A
公开(公告)日:1997-11-04
申请号:US525871
申请日:1995-09-08
IPC分类号: C07D333/22 , A61K31/12 , A61K31/135 , A61K31/38 , A61K31/381 , A61K31/44 , A61K31/4418 , A61P1/00 , A61P1/12 , A61P9/10 , A61P11/00 , A61P11/08 , A61P29/00 , C07C13/28 , C07C25/18 , C07C39/17 , C07C39/23 , C07C43/21 , C07C43/23 , C07C49/657 , C07C49/683 , C07C49/693 , C07C49/697 , C07C49/747 , C07C49/753 , C07C69/712 , C07C69/738 , C07C69/96 , C07C205/45 , C07C211/45 , C07C211/50 , C07C211/52 , C07C225/22 , C07D213/50 , C07C45/45
CPC分类号: C07C205/45 , C07C225/22 , C07C49/657 , C07C49/683 , C07C49/697 , C07C49/747 , C07C49/753 , C07C69/738 , C07C2101/08 , C07C2101/10
摘要: The invention relates to the use of substituted cyclopentane-diones and cyclopentane-triones for the preparation of medicaments which as chloride channel blockers are suitable for controlling airway diseases, secretory diarrhea and inflammatory diseases.
摘要翻译: 本发明涉及取代的环戊烷二酮和环戊烷二硫代磷酸酯用于制备药物的用途,其作为氯化物通道阻断剂适合于控制气道疾病,分泌性腹泻和炎性疾病。